Clinical Trials Logo

Clinical Trial Summary

Collagen VI-related diseases include Bethlem myopathy and Ulrich dystrophy. They are both caused by decreased levels or a lack of collagen VI. The first symptoms can be present at birth as joint laxity and hypotonic muscles; often seen with luxation of the hip and scoliosis. During childhood, patients may develop contractures of fingers, wrists, elbows and ankles. Muscle weakness often appears in childhood to early adulthood and is progressive. It often results in walking difficulties.

There is no treatment available for Behtlem and Ulrich dystrophies.

The primary aim of this study is to investigate the pattern of involved muscles, the function and quality of the muscles and the disease severity using MRI.


Clinical Trial Description

See above ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03693898
Study type Interventional
Source Rigshospitalet, Denmark
Contact Ruth Salim, stud.med
Phone +45 24 64 84 87
Email ruth.salim.01@regionh.dk
Status Recruiting
Phase N/A
Start date September 1, 2018
Completion date May 1, 2019

See also
  Status Clinical Trial Phase
Completed NCT01895283 - The Effect of Aerobic Exercise, on Fitness and Functional Muscle Strength, in Patients With Muscular Dystrophy N/A
Completed NCT01438788 - Low Protein Diet in Patients With Collagen VI Related Myopathies Phase 2
Recruiting NCT04020159 - Global Registry for COL6-related Dystrophies